Drug Landscape ›
Ibuprofen 400 mg ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 66
Most-reported reactions
Toxicity To Various Agents — 14 reports (21.21%) Intentional Overdose — 10 reports (15.15%) Hypotension — 7 reports (10.61%) Acute Kidney Injury — 6 reports (9.09%) Drug Interaction — 6 reports (9.09%) Myalgia — 6 reports (9.09%) Dyspnoea — 5 reports (7.58%) Cholestasis — 4 reports (6.06%) Diarrhoea — 4 reports (6.06%) Drug-Induced Liver Injury — 4 reports (6.06%)
Source database →
Ibuprofen 400 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ibuprofen 400 mg approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Ibuprofen 400 mg in United States?
ASST Fatebenefratelli Sacco is the originator. The local marketing authorisation holder may differ — check the official source linked above.